VTVT: vTv Therapeutics Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 60.80
Enterprise Value ($M) 57.67
Book Value ($M) -18.55
Book Value / Share -7.62
Price / Book -3.28
NCAV ($M) -18.91
NCAV / Share -7.77
Price / NCAV -3.22

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.70
Return on Equity (ROE) -49.63

Liquidity (mrq)
Quick Ratio 1.00
Current Ratio 1.00

Balance Sheet (mrq) ($M)
Current Assets 10.66
Assets 11.02
Liabilities 29.57
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -25.50
Net Income -20.25
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -19.08
Cash from Investing 4.40
Cash from Financing 12.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-22 13D/A MacAndrews & Forbes Inc. 50.30 -97.50
03-05 13D Baker Bros. Advisors Lp 4.99
03-05 13D Samsara BioCapital, L.P. 10.40

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-19 272 1,917 14.19
2024-04-18 451 3,410 13.23
2024-04-17 3,244 16,497 19.66
2024-04-16 367 5,229 7.02
2024-04-15 1,965 11,659 16.85

(click for more detail)

Similar Companies
VRPX – Virpax Pharmaceuticals, Inc. VSTM – Verastem, Inc.
VTGN – Vistagen Therapeutics, Inc. VXRT – Vaxart, Inc.
VYNE – VYNE Therapeutics Inc.


Financial data and stock pages provided by
Fintel.io